Neutralizing Antibody Activity to Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) and Omicron (B.1.1.529) after 1 or 2 Doses of BNT162b2 Vaccine in Infection-Naive and Previously Infected Individuals
James N. Moy, Mark Anderson, Xiaoying Shen, Jia Fu, Michael Stec, Amy Gosha, Dina Naquiallah, Jennifer Kinslow, David C. Montefiori, Gavin Cloherty, Alan Landay
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Neutralizing Antibody Activity to Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) and Omicron (B.1.1.529) after 1 or 2 Doses of BNT162b2 Vaccine in Infection-Naive and Previously Infected Individuals'. Together they form a unique fingerprint.